Table 1.

Patient characteristics

Total	20
Age (median, range)	68 (45-87)
	n (%)
Sex
Male	13 (65%)
Female	7 (35%)
ECOG performance status at baseline
0-1	18 (90%)
2	2 (10%)
Site of primary
Gastric	8 (40%)
Non-gastric	12 (60%)
Previous treatment lines
2	16 (80%)
3	4 (20%)
Mutational analysis
KIT exon 11 mutation	12 (60%)
KIT exon 9 mutation	1 (5%)
PDGFR D842V mutation	1 (5%)
Not avalilable	6 (30%)